{
    "nct_id": "NCT03331367",
    "official_title": "Investigating and Characterizing the Immune Response to Prostate Cancer",
    "inclusion_criteria": "* Patient is willing and able to freely sign informed consent to enroll in the study.\n* Histologically proven Prostate Carcinoma.\n* Undergoing total cryotherapy, focal cryotherapy, Cyberknife SBRT or radical prostatectomy for prostate cancer treatment.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Has previously had a radical prostatectomy for prostate cancer.\n* Has previously received cryotherapy for prostate cancer.\n* Previous treatment with chemotherapy within the past 6 months.\n* Previous treatment with radiation within the past 18 months.\n* Has evidence of metastatic disease.\n* Has a current or history within the past 6 months of alcohol and/or substance abuse which would impair participation in the study.\n* Has a major medical disorder (i.e. uncontrolled diabetes, significant hepatic, renal or hematological disorders, recent stroke or myocardial infarction), in the opinion of the urologist, is an illness or complication which is not consistent with the protocol requirements.\n* Is not willing to undergo the necessary follow-up for the trial period.\n* Has known immunologic disease, human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness.",
    "miscellaneous_criteria": ""
}